Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says

The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer's diagnosis in diabetes patients.

...

Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity

2 weeks ago

Palo Alto shares helped by contract news, Abbott Labs braces for lawsuit ruling

2 weeks ago

Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial

3 weeks ago

CVS, UnitedHealth, Cigna sue to block FTC case over insulin prices

3 weeks ago

Healthy Returns: Trump’s FDA pick Makary may be a relief for biotech and pharma, analysts say

2 weeks ago